Efficacy of Jiedu Tongluo Tiaogan Formula on Type 2 Diabetic Lower Extremity Arteriosclerosis Obliterans: Study Protocol for a Metabolomics-Based Randomized Controlled Clinical Trial

Tianjiao Liu, Chunli Piao, Yuting Peng, Jinghan Xu, Yue Qu, Qi Li, Xiaohua Zhao, Xuemin Wu, Pei Li, Yawen Fan
doi: https://doi.org/10.1101/2022.06.25.22276893

Article Information

doi 
https://doi.org/10.1101/2022.06.25.22276893
History 
  • June 27, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Tianjiao Liu1,
  2. Chunli Piao1,*,
  3. Yuting Peng1,
  4. Jinghan Xu1,
  5. Yue Qu1,
  6. Qi Li1,
  7. Xiaohua Zhao1,
  8. Xuemin Wu1,
  9. Pei Li1 and
  10. Yawen Fan1
  1. 1Institution of Shenzhen Hospital, Guangzhou University of Chinese Medicine (Futian), Shenzhen 518000, Guangdong Province, P.R. China
  1. ↵*Correspondence: Chunli Piao, pcl2013{at}sina.cn
Back to top
Posted June 27, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Efficacy of Jiedu Tongluo Tiaogan Formula on Type 2 Diabetic Lower Extremity Arteriosclerosis Obliterans: Study Protocol for a Metabolomics-Based Randomized Controlled Clinical Trial
Tianjiao Liu, Chunli Piao, Yuting Peng, Jinghan Xu, Yue Qu, Qi Li, Xiaohua Zhao, Xuemin Wu, Pei Li, Yawen Fan
medRxiv 2022.06.25.22276893; doi: https://doi.org/10.1101/2022.06.25.22276893
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area